Adaptive Biotechnologies: MRD 业务剥离打造纯度更高的复合增长企业 (NASDAQ:ADPT)
· seekingalpha.com
Adaptive Biotechnologies (ADPT) 转向专注于微小残留病 (MRD) 诊断，clonoSEQ 的采用率、利润率和积压订单均大幅飙升。
My current bullish outlook on Adaptive Biotechnologies Corporation ( ADPT ) stems from the economic and financial change in the business rather than the science...